OTHER FUNCTION; N01DA-12-8905; PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOR M

Vince And Associates Clinical Research,, Overland Park KS

Investigators

Abstract

The National Institute on Drug Abuse (NIDA) supports research and development of new medications for the treatment of substance use disorders. Medication development is a long and complex process. It involves the design of new drugs, preclinical evaluations, pharmaceutical development and clinical evaluations. A critical aspect of the clinical evaluations involves studies to determine the clinical pharmacokinetics (PK) and pharmacodynamics (PD) of the new medications under development.